Patent settlements still rising, but potentially troublesome deals stable, says EC
This article was originally published in Scrip
Executive Summary
The number of patent settlements between originator and generic companies in Europe continued to rise in 2012, but the proportion of deals that could attract scrutiny under competition law issues has stabilized at a low level, suggesting that companies are more aware of potentially problematic practices, says the European Commission.